Washington, United States—President Joe Biden's outgoing administration on Thursday announced $211 million in new funding to develop mRNA vaccines against emerging biothreats and said it...
The US pharmaceutical giant Pfizer sharply scaled back its earnings outlook for the year, blaming lower-than-expected sales of two drugs used to treat Covid-19,...
GlaxoSmithKline sued Pfizer on Wednesday over patent infringement, alleging the US drugmaker's RSV vaccine steals key elements of the British company's version.
The case, filed...
The Department of Health (DOH) has announced that the emergency use authorization (EUA) for the bivalent vaccines against COVID-19 has been released and the...
In response to the prevailing threat of breast cancer in the Philippines, Pfizer has introduced a trastuzumab biosimilar to enable more Filipinos to have...
Moderna said Friday it is suing rival vaccine makers Pfizer and BioNTech, alleging the partners infringed on its patents in developing their COVID-19 shot...
Health Secretary Francisco Duque III has approved the Health Technology Assessment Council's (HTAC) recommendation to administer the first Pfizer COVID-19 booster shots for children...
US health authorities on Saturday cleared the Pfizer and Moderna COVID-19 vaccines for children aged five and younger, in a move President Joe Biden...
A frontliner administers a Pfizer COVID-19 booster shot to a churchgoer on April 24. Vaccination sites have been opened in various places in Manila....
The government has not yet purchased stocks of the oral COVID-19 pill Paxlovid because Pfizer is requiring an indemnification law before it sells the...
